Filter Results :

Your search for T-Cell returned 31 reports

Sort by


Peripheral T-Cell Lymphomas (PTCL) - Pipeline Insights, 2017

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight’s, “Peripheral T-Cell Lymphoma (PTCL)-Pipeline Insights, 2017”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Peripheral T-Cell Lymphoma (PTCL...

$ 1,250.00

Read More

Peripheral T-Cell Lymphomas (PTCL) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight’s, Peripheral T-Cell Lymphomas (PTCL) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017” report provides comprehensive insights about marketed and Phase III products for the Peripheral T-Cell Lymphomas (PTCL). The report includes information of marketed products i...

$ 2,250.00

Read More

Peripheral T-Cell Lymphoma - Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2023

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight’s ‘Peripheral T-Cell Lymphoma (PTCL) - Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2025’ report provides provides the comprehensive insights on the competitive landscape and market of Peripheral T-Cell Lymphoma (PTCL).The report covers an overview of the Per...

$ 6,950.00

Read More

Cutaneous T-Cell Lymphoma - Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2025

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight’s “Actinic Keratosis– Competitive Landscape, Market Insights, Epidemiology and Market Forecast-2025”report provides the comprehensive insights on the competitive landscape and market of Actinic Keratosis (AK).The Report covers an overview of the disease and global market trends of the A...

$ 6,950.00

Read More

Cutaneous T-Cell Lymphoma(CTCL)- Epidemiology Insights to 2025

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight “ Cutaneous T-Cell Lymphoma(CTCL) - Epidemiology Forecast To 2025” provides an overview of the epidemiology trends of Cutaneous T-Cell Lymphoma(CTCL) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted dat...

$ 2,950.00

Read More

Peripheral T-Cell Lymphoma (PTCL)- Epidemiology Insights to 2025

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight “ Peripheral T-Cell Lymphoma (PTCL) - Epidemiology Forecast To 2025” provides an overview of the epidemiology trends of Peripheral T-Cell Lymphoma (PTCL) in seven major markets (US, France, Germany, Italy, Spain, UK and Japan). It includes 10 years epidemiology historical and forecasted...

$ 2,950.00

Read More

Cutaneous T-Cell Lymphoma(CTCL) - Market Insights, Epidemiology and Market Forecast-2025

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight’s “Cutaneous T-Cell Lymphoma(CTCL) - Market Insights, Epidemiology and Market Forecast – 2025” Reports provides an overview of the disease and global market size of the Cutaneous T-Cell Lymphoma(CTCL) for the 7MM (United States, Germany, France, Italy, Spain and UK). The Report covers t...

$ 5,750.00

Read More

Peripheral T-Cell Lymphoma (PTCL) - Market Insights, Epidemiology and Market Forecast-2025

01 Jul 2017  |  Published by:  DelveInsight
DelveInsight’s “Peripheral T-Cell Lymphoma (PTCL) - Market Insights, Epidemiology and Market Forecast – 2025” Reports provides an overview of the disease and global market size of the Peripheral T-Cell Lymphoma (PTCL) for the 7MM (United States, Germany, France, Italy, Spain and UK). The Report cove...

$ 5,750.00

Read More

T-Cell Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jun 2017  |  Published by:  DelveInsight
T-Cell Leukemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the T-Cell Leukemia Report is to understand the mark...

$ 2,000.00

Read More

T-Cell Lymphomas-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jun 2017  |  Published by:  DelveInsight
T-Cell Lymphomas-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the T-Cell Lymphomas Report is to understand the ma...

$ 2,000.00

Read More

T-Cell Leukemia-Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s, “ T-Cell Leukemia-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the T-Cell Leukemia. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IN...

$ 1,250.00

Read More

T-Cell Lymphomas-Pipeline Insights, 2017

01 Jun 2017  |  Published by:  DelveInsight
DelveInsight’s, “ T-Cell Lymphomas-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the T-Cell Lymphomas. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, ...

$ 1,250.00

Read More

Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017

01 Jun 2017  |  Published by:  DelveInsight
Cutaneous T-Cell Lymphoma-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturers across the globe. A key objective of the Cutaneous T-Cell Lymphoma Report is to...

$ 2,000.00

Read More

Cutaneous T-Cell Lymphoma Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jun 2017  |  Published by:  DelveInsight
Summary'Cutaneous T-Cell Lymphoma- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for A...

$ 2,000.00

Read More

Peripheral T-Cell Lymphomas (PTCL) Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014

01 Jun 2017  |  Published by:  DelveInsight
Summary'Peripheral T-Cell Lymphomas (PTCL)- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014', report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understand...

$ 2,000.00

Read More
Total 31 records.